Molecular markers in male breast carcinoma.

  title={Molecular markers in male breast carcinoma.},
  author={Daniel Rayson and Charles E Erlichman and Vera J. Suman and Patrick C. Roche and Lester E. Wold and James N. Ingle and John Harrington Donohue},
  volume={83 9},
BACKGROUND In contrast to female breast carcinoma, information regarding the prevalence and prognostic information of new molecular markers is limited in male breast carcinoma. The objective of this study was to assess the degree of expression and prognostic value of estrogen receptors (ER), progesterone receptors (PR), androgen receptors (AR), bcl-2, p53, HER-2/neu, cyclin D1, and MIB-1 in a cohort of male breast carcinoma patients. METHODS A computerized search of the medical index, tumor… CONTINUE READING
51 Citations
61 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 51 extracted citations


Publications referenced by this paper.
Showing 1-10 of 61 references

Asymptotically efficient rank invariant procedures [with discussion

  • R Peto, J. Peto
  • J R Stat Soc A 1972;135:185–207
  • 1972
Highly Influential
9 Excerpts

Hanley-Hyde J. G1 cyclins and control of the cell division cycle in normal and transformed cells

  • PA Hamel
  • Cancer Invest
  • 1997
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…